<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0005110'>Atrial fibrillation</z:hpo> (AF) is a common <z:hpo ids='HP_0011675'>cardiac arrhythmia</z:hpo> associated with an increased morbidity and mortality, and much of the AF-associated morbidity is secondary to a five-fold to six-fold increased risk of <z:hpo ids='HP_0001297'>stroke</z:hpo> and <z:hpo ids='HP_0001907'>thromboembolism</z:hpo>(1) </plain></SENT>
<SENT sid="1" pm="."><plain>The <z:hpo ids='HP_0001297'>stroke</z:hpo> risk in AF patients is not homogeneous, but depends on the presence of other underlying clinical conditions(2) </plain></SENT>
<SENT sid="2" pm="."><plain>To aid decision-making for thromboprophylaxis, several clinical risk stratification schemes have been developed using various risk factors and clinical characteristics. Â© 2012 International Society on <z:mp ids='MP_0005048'>Thrombosis</z:mp> and Haemostasis </plain></SENT>
</text></document>